Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Santos, Cláudia Yanga | Lim, Yen Yingb; c | Wu, Wen-Chihd | Machan, Jason Timothye | Polynice, Shahenaf | Schindler, Rachelg | Maruff, Paulc; h | Snyder, Peter Jeffreya; b; *
Affiliations: [a] Interdisciplinary Neuroscience Program, University of Rhode Island, Kingston, RI, USA | [b] Department of Neurology, Alpert Medical School of Brown University, Providence, RI, USA | [c] The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia | [d] Division of Cardiology, Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA | [e] Lifespan Biostatistics Core, Lifespan Hospital System, Providence, RI, USA | [f] Department of Neuroscience, Brown University, Providence, RI, USA | [g] Pfizer Inc., New York, NY, USA | [h] Cogstate Ltd., Melbourne, Victoria, Australia
Correspondence: [*] Correspondence to: Peter J. Snyder, PhD, Suite 1.001, 1 Hoppin Street, Providence, RI 02903, USA. Tel.: +1 401 444 4117; Fax: +1 401 444 4100; E-mail: psnyder@lifespan.org.
Abstract: We sought to determine whether there is any association between a cardiac workload marker, rate pressure product (RPP), working memory, and cortical amyloid-β (Aβ) burden in 63 cognitively normal midlife adults (Mage = 62.8 years; range = 55 to 75 years) at risk for Alzheimer’s disease (AD). The results show a small-to-moderate relationship between increasing cardiac workload (at rest) and neocortical amyloidosis in individuals at the preclinical stage of AD. Moreover, increasing RPP was linearly related to increasing relative impairments on a spatial working memory task (R2 = 0.30), but only for those individuals with neuroimaging evidence suggestive of preclinical AD. These results support a relationship between the aggregation of Aβ protein plaques in the neocortex, increased cognitive impairment, and more inefficient myocardial oxygen use in the absence of significant metabolic demands.
Keywords: Alzheimer’s disease, amyloid beta-peptides, blood pressure, cardiovascular diseases, cerebrovascular disorders, comorbidity, memory, mild cognitive impairment, risk factors, short-term, workload
DOI: 10.3233/JAD-150576
Journal: Journal of Alzheimer's Disease, vol. 50, no. 1, pp. 127-131, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl